RAC1 and colorectal carcinoma: While future studies directly testing the relationship between RAC1 and RAC1B and cetuximab resistance in CRC are needed, the evidence summarized in this review provides strong support for a role for RAC1 and RAC1B in intrinsic and acquired resistance to cetuximab (Figure 4).